Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
67%(4 trials)
Terminated
1(8%)

Phase Distribution

Ph early_phase_1
1
8%
Ph not_applicable
6
46%
Ph phase_2
1
8%
Ph phase_3
4
31%
Ph phase_4
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
4(30.8%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
6(46.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(5)

Detailed Status

Completed6
unknown5
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 21 (7.7%)
Phase 34 (30.8%)
Phase 41 (7.7%)
N/A6 (46.2%)

Trials by Status

not_yet_recruiting18%
unknown538%
terminated18%
completed646%

Recent Activity

0 active trials
Showing 5 of 13
not_yet_recruitingphase_3

Lidocaine Patch and Lower Third Molar

NCT07330726
completedphase_2

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

NCT05783219
completedphase_3

Lidocaine Patches After Cesarean Section

NCT04443569
completednot_applicable

Lidocaine Patch for Neck Pain

NCT04378959
completedphase_3

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

NCT04822597
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07330726Phase 3

Lidocaine Patch and Lower Third Molar

Not Yet Recruiting
NCT05783219Phase 2

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

Completed
NCT04443569Phase 3

Lidocaine Patches After Cesarean Section

Completed
NCT04378959Not Applicable

Lidocaine Patch for Neck Pain

Completed
NCT04822597Phase 3

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

Completed
NCT04033562Phase 4

The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

Terminated
NCT04517890Not Applicable

Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System

Unknown
NCT04518189Not Applicable

Transdermal Lidocaine for Pain Control During Hysterosalpingography

Unknown
NCT04518202Not Applicable

Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Unknown
NCT04505644Not Applicable

Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section

Unknown
NCT03145207Early Phase 1

PK and DPK of Lidocaine Dermal Products

Completed
NCT02812602Not Applicable

Topical Anesthesia for Removal of Stitches After Total Knee Arthroplasty

Unknown
NCT01443325Phase 3

Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13